From large cells to nuclei: Key considerations for everyday sorting... Register Now Help over 2 million scientists like you save time, money & resources Be the first to review brand new products Exclusive perks, regular competitions, prizes and member-only events Give vital feedback to manufacturers & help shape new technologies KINOMEscan™ Binding Assays by DiscoveRx CorporationManufacturer DiscoveRx CorporationBe the first to review this productThe KINOMEscan screening platform employs a novel and proprietary active site-directed competition binding assay to quantitatively measure interactions between test compounds and more than 450 kinase assays and disease relevant mutant variants. This robust and reliable assay technology affords investigators the ability to extensively annotate compounds with accurate, precise and reproducible data. KINOMEscan assays do not require ATP and thereby report true thermodynamic interaction affinities, ... Read more KINOMEscan™ Binding Assays Reviews Description Application Notes0 Scientists have reviewed this product Write the First Review No Reviews The KINOMEscan screening platform employs a novel and proprietary active site-directed competition binding assay to quantitatively measure interactions between test compounds and more than 450 kinase assays and disease relevant mutant variants. This robust and reliable assay technology affords investigators the ability to extensively annotate compounds with accurate, precise and reproducible data. KINOMEscan assays do not require ATP and thereby report true thermodynamic interaction affinities, as opposed to IC50 values, which can depend on the ATP concentration.

KINOMEscan Platform Benefits & Features: Rapid turnaround time Largest commercially available kinase assay panel Flexible: screen any number of compounds against any number of kinases Custom panel capabilities to support ongoing drug discovery programs High throughput: >4000 compounds per month screened across full panel (>1.7 million interactions) Accurate affinity (Kd) measurements from 10 uM ATP not required: delivers true thermodynamic affinity data as opposed to IC50s Includes clinically relevant catalytically inactive pseudokinases (e.g. ERBB3) Includes activation state-specific assays that provide inhibitor binding mode information No interference from compound fluorescence All assays performed in parallel under standardized conditions as a single experimentAccurate, precise, reproducible data High Throughput, Quantitative Ligand Binding Assays for Human BromodomainsExploring & Exploiting Allosteric Inhibitors & Covalent Inhibitors Why request a quote through SelectScience?

Easy It’s quick and simple to do

Fast Your inquiry will be delivered straight to the manufacturer

Free You’re under no obligation

Secure We only pass your details on to trusted suppliers at your request

Save time Submit your details once and make multiple inquiries

>>> 更多资讯详情请访问蚂蚁淘商城